Galapagos reported EUR185.62M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
AstraZeneca AZN:LN USD 9.74B 495M
Biogen BIIB:US USD 1.19B 1.45B
Genmab GEN:DC DKK 2.16B 241M
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Hikma Pharmaceutical HIK:LN USD 964M 118M
Merck MRK:GR EUR 4.57B 181M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NOVN:VX USD 10.67B 183M
Roche Holding ROG:VX 20.75B 3.26B
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
YTE INCY:US USD 684.93M 27.96M